Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-04-12
2011-04-12
Gabel, Gailene R (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007230, C435S007240, C435S007250, C435S007940, C436S517000, C436S518000, C436S522000, C436S523000, C436S538000, C436S174000, C436S177000, C424S009200
Reexamination Certificate
active
07923210
ABSTRACT:
The present invention provides methods, diagnostic assays, and diagnostic kits based on said methods, to determine levels of immunosuppressive complexes containing immunosuppressive drugs tacrolimus, sirolimus and cyclosporine A separately and in combination, formed in the blood of a drug-treated patient or in a patient candidate to immunosuppressive drug therapy. These methods, assays and kits are especially useful when using automated systems.
REFERENCES:
patent: 5576183 (1996-11-01), Kobayashi et al.
patent: 5756301 (1998-05-01), Erlanger et al.
patent: 5811525 (1998-09-01), Rittershaus
patent: 5936070 (1999-08-01), Singh et al.
patent: 6338946 (2002-01-01), Kobayashi et al.
patent: 6613739 (2003-09-01), Naicker et al.
patent: 2006/0014677 (2006-01-01), Mayo
patent: 0750193 (1996-12-01), None
Abraham, et al., “Immunopharmacology of Rapamycin”, Ann. Rev. Immunol., vol. 14, pp. 483-510, 1996.
Alak, A., “Measurement of Tacrolimus (FK506) and its Metabolites: A Review of Assay Development and application in Therapeutic Drug Monitoring and Pharmacokinetic Studies”, Therap. Drug. Monit., vol. 19, pp. 338-351, 1997.
Armstrong, et al., “Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II)”, Clin. Chemistry, vol. 44, pp. 2516-2523, 1998.
Cardenas, et al., “Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin”, Current Opinion in Nephrology and Hypertension, vol. 4, No. 6, pp. 472-477, 1995.
Carreras, et al., An FKBP12 Binding Assay Based upon Biotinylated FKBP12, Analytical Biochemistry, vol. 298, Issue 1, pp. 57-61, Nov. 1, 2001.
Griffith, et al., “X-ray Structure of Calcineurin Inhibited by the Immunophilin-Immunosuppressant FKBP-12-FKB506 Complex”, Cell, vol. 82, pp. 507-522, Aug. 11, 1995.
Kissinger, et al., “Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex”, Nature, vol. 378, pp. 641-644, Dec. 7, 1995.
Mota, “Sirolimus: a new option in transplantation”, Expert Opinion on Pharmacotherapy, vol. 6, No. 3, pp. 479-487, Mar. 2005.
Sabers, et al., “Isolation of Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells”, The Journal of Biological Chemistry, vol. 270, No. 2, pp. 815-822, 1995.
PCT International Application No. PCT/US2006/012988, Search Report and Written Opinion of the International Searching Authority mailed Sep. 26, 2006.
Baugher Bennett W.
Drengler Susan M.
Abbott Laboratories
Bartnicki Audrey L.
Gabel Gailene R
Larcher Carol
Larcher & Chao Law Group
LandOfFree
Methods to measure immunosuppressive tacrolimus, sirolimus,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods to measure immunosuppressive tacrolimus, sirolimus,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods to measure immunosuppressive tacrolimus, sirolimus,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2715484